These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients. Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064 [TBL] [Abstract][Full Text] [Related]
3. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499 [TBL] [Abstract][Full Text] [Related]
4. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
5. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway. Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110 [TBL] [Abstract][Full Text] [Related]
6. FLT3 and acute myeloid leukemia: what is the wild type receptor up to? Levis M Haematologica; 2005 Dec; 90(12):1586. PubMed ID: 16330422 [No Abstract] [Full Text] [Related]
7. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Whitman SP; Archer KJ; Feng L; Baldus C; Becknell B; Carlson BD; Carroll AJ; Mrózek K; Vardiman JW; George SL; Kolitz JE; Larson RA; Bloomfield CD; Caligiuri MA Cancer Res; 2001 Oct; 61(19):7233-9. PubMed ID: 11585760 [TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies. Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246 [TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication. Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839 [TBL] [Abstract][Full Text] [Related]
10. Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome. Shih LY; Lin TL; Wang PN; Wu JH; Dunn P; Kuo MC; Huang CF Cancer; 2004 Sep; 101(5):989-98. PubMed ID: 15329908 [TBL] [Abstract][Full Text] [Related]
11. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia. Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862 [TBL] [Abstract][Full Text] [Related]
13. Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Moreno I; Martín G; Bolufer P; Barragán E; Rueda E; Román J; Fernández P; León P; Mena A; Cervera J; Torres A; Sanz MA Haematologica; 2003 Jan; 88(1):19-24. PubMed ID: 12551822 [TBL] [Abstract][Full Text] [Related]
14. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia. Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance]. Wang YG; Liu XH; Liang Y; Jin J Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010 [TBL] [Abstract][Full Text] [Related]
16. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance]. Wang J; Wang T; Li S; Lin L; Gang Y Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369 [TBL] [Abstract][Full Text] [Related]
17. Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype. Palmieri S; Ferrara F; Leoni F; Ciolli S; Pollio F; D'Amico MR; Celentano M; Viola A; Vicari L; Izzo B; Pane F Hematol Oncol; 2007 Mar; 25(1):1-5. PubMed ID: 17036374 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation. Jiang A; Jiang H; Brandwein J; Kamel-Reid S; Chang H Leuk Res; 2011 Apr; 35(4):492-8. PubMed ID: 20684989 [TBL] [Abstract][Full Text] [Related]
19. The influence of age on prognosis of de novo acute myeloid leukemia differs according to cytogenetic subgroups. Schoch C; Kern W; Schnittger S; Büchner T; Hiddemann W; Haferlach T Haematologica; 2004 Sep; 89(9):1082-90. PubMed ID: 15377469 [TBL] [Abstract][Full Text] [Related]
20. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]